146 related articles for article (PubMed ID: 38529549)
1. Olanzapine Liquisolid Tablets Using Kolliphor EL with Improved Flowability and Bioavailability:
Korni RD; Gonugunta CSR
Turk J Pharm Sci; 2024 Mar; 21(1):52-61. PubMed ID: 38529549
[TBL] [Abstract][Full Text] [Related]
2. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
Fahmy RH; Kassem MA
Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
[TBL] [Abstract][Full Text] [Related]
4. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation.
Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ
Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143
[TBL] [Abstract][Full Text] [Related]
6. Upgrading of dissolution and anti-hypertensive effect of Carvedilol via two combined approaches: self-emulsification and liquisolid techniques.
Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM
Drug Dev Ind Pharm; 2018 Jun; 44(6):873-885. PubMed ID: 29254384
[TBL] [Abstract][Full Text] [Related]
7. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
8. Development of 3D-Printed, Liquisolid and Directly Compressed Glimepiride Tablets, Loaded with Black Seed Oil Self-Nanoemulsifying Drug Delivery System: In Vitro and In Vivo Characterization.
Ahmed TA; Alotaibi HA; Alharbi WS; Safo MK; El-Say KM
Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056126
[TBL] [Abstract][Full Text] [Related]
9. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies.
Karmarkar AB
Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315
[TBL] [Abstract][Full Text] [Related]
10. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor(®) El-Based Liquisolid Tablets.
Yehia SA; El-Ridi MS; Tadros MI; El-Sherif NG
Adv Pharm Bull; 2015 Nov; 5(4):569-81. PubMed ID: 26819931
[TBL] [Abstract][Full Text] [Related]
12. Incorporating valsartan in sesame oil enriched self-nanoemulsifying system-loaded liquisolid tablets to improve its bioavailability.
El-Say KM; Alamri SH; Alsulimani HH; Alharbi WS; Omar AM; Safo MK; Ahmed TA
Int J Pharm; 2023 May; 639():122966. PubMed ID: 37084835
[TBL] [Abstract][Full Text] [Related]
13. In vitro release evaluation of hydrocortisone liquisolid tablets.
Spireas S; Sadu S; Grover R
J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
[TBL] [Abstract][Full Text] [Related]
14. Design and Characterization of Buccoadhesive Liquisolid System of an Antihypertensive Drug.
Kala NP; Shastri DH; Shelat PK
J Drug Deliv; 2015; 2015():574247. PubMed ID: 26579235
[TBL] [Abstract][Full Text] [Related]
15. Studies on Preformulation and Formulation of JIN-001 Liquisolid Tablet with Enhanced Solubility.
Kim HS; Kim CM; Jo AN; Kim JE
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455409
[TBL] [Abstract][Full Text] [Related]
16. Development and Characterization of Liquisolid Tablets Based on Mesoporous Clays or Silicas for Improving Glyburide Dissolution.
Cirri M; Mura P; Valleri M; Brunetti L
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32492869
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability.
Thakkar HP; Vasava D; Patel AA; Dhande RD
Ther Deliv; 2020 Feb; 11(2):83-96. PubMed ID: 31955698
[No Abstract] [Full Text] [Related]
18. Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology.
Lam M; Ghafourian T; Nokhodchi A
AAPS PharmSciTech; 2019 Jun; 20(6):231. PubMed ID: 31236781
[TBL] [Abstract][Full Text] [Related]
19. Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability.
Khames A
Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30669353
[TBL] [Abstract][Full Text] [Related]
20. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts.
Javadzadeh Y; Shariati H; Movahhed-Danesh E; Nokhodchi A
Drug Dev Ind Pharm; 2009 Feb; 35(2):243-51. PubMed ID: 18785038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
